Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Insect Venom Allergenic Extract [EPC]
Castanea Sativa Leaf extract is a biological allergenic agent used for the diagnosis and treatment of hypersensitivity. It belongs to the class of Non-Standardized Plant Allergenic Extracts used in immunotherapy and skin testing.
Name
Castanea Sativa Leaf
Raw Name
CASTANEA SATIVA LEAF
Category
Standardized Insect Venom Allergenic Extract [EPC]
Drug Count
10
Variant Count
10
Last Verified
February 17, 2026
About Castanea Sativa Leaf
Castanea Sativa Leaf extract is a biological allergenic agent used for the diagnosis and treatment of hypersensitivity. It belongs to the class of Non-Standardized Plant Allergenic Extracts used in immunotherapy and skin testing.
Detailed information about Castanea Sativa Leaf
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Castanea Sativa Leaf.
Castanea Sativa Leaf, commonly known as the leaf of the Sweet Chestnut tree, is utilized in clinical medicine primarily as an allergenic extract. It belongs to a pharmacological class known as Non-Standardized Plant Allergenic Extracts [EPC]. These substances are biological products regulated by the FDA's Center for Biologics Evaluation and Research (CBER). Unlike conventional synthetic drugs, Castanea Sativa Leaf extract is a complex mixture of proteins, glycoproteins, and polysaccharides derived from the plant material. Its primary clinical utility lies in the field of allergy and immunology, specifically for the diagnosis of Type I hypersensitivity (immediate-type allergy) and as a component of allergen immunotherapy (AIT).
In the context of diagnostic medicine, Castanea Sativa Leaf extract is used in skin prick testing (SPT) to identify patients who have developed specific IgE antibodies against the proteins found in the chestnut plant. For therapeutic purposes, it is used in subcutaneous immunotherapy (SCIT), a process often referred to as "allergy shots." The goal of this therapy is to induce immunological tolerance in patients who suffer from allergic rhinitis, conjunctivitis, or asthma triggered by exposure to chestnut pollen or related environmental allergens. The FDA has a long history of regulating these extracts, transitioning many from old-world biological licenses to modern Biologics License Applications (BLA) to ensure safety and potency, though many plant extracts remain "non-standardized," meaning their potency is not measured in specific bioequivalent units but rather by weight/volume ratios.
The mechanism of action for Castanea Sativa Leaf extract depends on its application. When used for diagnosis, the extract is introduced into the epidermis. If the patient is sensitized, specific IgE antibodies bound to the surface of mast cells will recognize the chestnut proteins. This recognition triggers mast cell degranulation, releasing histamine and other inflammatory mediators, which results in a visible "wheal and flare" reaction (a raised bump surrounded by redness). This is a localized, controlled version of an allergic reaction used to confirm sensitivity.
When used therapeutically in immunotherapy, the mechanism is more complex and involves a fundamental shift in the patient's immune system. Repeated, escalating doses of Castanea Sativa Leaf extract are administered to the patient. Over time, this exposure promotes a shift from a Th2-dominated immune response (which produces IgE and promotes allergy) to a Th1-dominated response. Furthermore, it induces the production of regulatory T-cells (Tregs) and B-cells. These regulatory cells secrete anti-inflammatory cytokines like Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-β). Additionally, the body begins producing IgG4 antibodies, which act as "blocking antibodies." These IgG4 molecules compete with IgE for the allergen-binding sites, effectively preventing the allergen from triggering mast cell activation. This molecular retraining of the immune system can lead to long-term remission of allergy symptoms.
Because Castanea Sativa Leaf extract is a biological protein mixture administered either epicutaneously or subcutaneously, its pharmacokinetic profile differs significantly from oral medications.
Castanea Sativa Leaf extract is primarily indicated for:
Castanea Sativa Leaf is available in several specialized formulations:
> Important: Only your healthcare provider can determine if Castanea Sativa Leaf is right for your specific condition. The administration of allergenic extracts must be performed by a trained professional in a facility equipped to handle severe allergic reactions.
Dosage for Castanea Sativa Leaf extract is highly individualized and must be determined by an allergist or immunologist based on the patient's sensitivity level and clinical history.
For skin prick testing, a single drop of the extract (typically 1:10 or 1:20 w/v) is applied to the skin, followed by a light puncture. Results are interpreted after 15 to 20 minutes. A positive result is generally defined as a wheal diameter 3mm larger than the negative control.
Immunotherapy follows a two-phase schedule:
Castanea Sativa Leaf extract is generally considered safe for use in children, typically those aged 5 years and older. Dosing protocols for children are similar to those for adults but require even more cautious escalation during the build-up phase. Children under 5 may be at higher risk for systemic reactions and may have difficulty communicating early symptoms of anaphylaxis; therefore, use in this age group is less common and must be carefully weighed by a specialist.
No specific dosage adjustments are required for patients with renal impairment, as the systemic protein load is negligible. However, the patient's overall health should be stable before administration.
No dosage adjustments are necessary for hepatic impairment, as the metabolism of allergenic proteins does not rely on hepatic enzyme pathways.
Caution is advised in elderly patients, particularly those with underlying cardiovascular disease. The risk of a systemic reaction (anaphylaxis) may be more dangerous in this population, and the use of epinephrine to treat such a reaction may pose cardiac risks.
This medication is never self-administered at home. It must be administered in a clinical setting (doctor's office or allergy clinic).
If an immunotherapy dose is missed, the next dose may need to be reduced depending on how much time has passed.
An overdose in the context of allergenic extracts refers to receiving a dose higher than the patient's current tolerance level. Signs of overdose include severe local swelling, hives, wheezing, or a drop in blood pressure (anaphylaxis).
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or skip appointments without medical guidance.
Most patients receiving Castanea Sativa Leaf extract will experience some form of local reaction. These are generally not dangerous but indicate the body's immune response to the allergen.
> Warning: Stop taking Castanea Sativa Leaf and call your doctor immediately if you experience any of these symptoms of anaphylaxis.
When used correctly, Castanea Sativa Leaf immunotherapy is intended to have a long-term beneficial effect by reducing allergy symptoms. However, rare long-term complications can include:
Allergenic extracts, including Castanea Sativa Leaf, carry a significant warning regarding the risk of severe systemic reactions.
Report any unusual symptoms to your healthcare provider. Even a large local reaction should be reported, as it may prompt your doctor to adjust your next dose.
Castanea Sativa Leaf extract is a potent biological agent. Its use is restricted to diagnostic and therapeutic protocols under the guidance of specialists. Patients must be in their baseline state of health before receiving an injection; if you have a fever, respiratory infection, or an active asthma flare-up, the injection should be postponed.
No FDA black box warnings for Castanea Sativa Leaf. However, it is subject to the general class warnings for all allergenic extracts. These warnings emphasize that allergenic extracts are not interchangeable. Potency units (if applicable) and concentrations vary between manufacturers. A change in the source of the extract requires a significant dose reduction and a new build-up phase to ensure patient safety.
Generally, Castanea Sativa Leaf does not cause drowsiness. However, if a patient experiences a systemic reaction or receives antihistamines/epinephrine to treat a reaction, they should not drive or operate machinery until the effects have completely worn off and they are medically cleared.
Alcohol should be avoided for several hours before and after an injection. Alcohol causes vasodilation (widening of blood vessels), which can increase the rate of allergen absorption and potentially increase the risk or severity of an allergic reaction.
Stopping immunotherapy abruptly does not cause a withdrawal syndrome like synthetic drugs. However, the benefits of the treatment may be lost if the maintenance phase is not completed. If you decide to stop, discuss the implications with your allergist.
> Important: Discuss all your medical conditions with your healthcare provider before starting Castanea Sativa Leaf.
For each major interaction, the primary concern is either the masking of diagnostic results or the interference with emergency treatment for anaphylaxis. Management strategies involve temporary discontinuation of interfering drugs (for testing) or choosing alternative therapies (for immunotherapy).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Patients sensitive to Castanea Sativa Leaf may show cross-reactivity to:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Castanea Sativa Leaf.
Castanea Sativa Leaf extract is classified as FDA Pregnancy Category C. This means there are no adequate, well-controlled studies in pregnant women. The primary concern is not direct teratogenicity (birth defects) from the extract itself, but rather the risk of anaphylaxis in the mother. A severe allergic reaction can lead to maternal hypotension and uterine contraction, resulting in fetal hypoxia (lack of oxygen to the baby).
It is generally considered safe to continue Castanea Sativa Leaf immunotherapy while breastfeeding. The allergenic proteins are not expected to pass into breast milk in any significant quantity that would affect the infant. The mother's immune response (IgG4 production) may even be beneficial, though this is not a primary reason for treatment.
Patients over 65 years of age require a thorough cardiovascular evaluation before starting Castanea Sativa Leaf. The risk-benefit ratio may be less favorable in this group due to the prevalence of heart disease and the use of medications like beta-blockers or ACE inhibitors. If treatment is deemed necessary, a slower build-up phase is often employed.
No specific GFR-based adjustments are documented for Castanea Sativa Leaf. The protein load is minimal and does not pose a risk for renal toxicity. However, patients with end-stage renal disease (ESRD) on dialysis should be treated with caution due to their overall fragile physiological state.
There are no dosage adjustments required for patients with liver disease. The clearance of these proteins is handled by general cellular catabolic processes and is not dependent on the Child-Pugh score or liver function tests.
> Important: Special populations require individualized medical assessment.
Castanea Sativa Leaf extract contains various allergenic proteins (antigens). Upon administration, these antigens are captured by Antigen-Presenting Cells (APCs), such as dendritic cells. In a sensitized individual, this leads to a rapid allergic response. However, during immunotherapy, the frequent exposure to these antigens at increasing doses induces a state of "anergy" or "tolerance" in T-lymphocytes. Specifically, it promotes the expansion of CD4+ CD25+ regulatory T-cells. These cells produce Interleukin-10 (IL-10), which suppresses the Th2 response and inhibits mast cell, basophil, and eosinophil activity. It also induces B-cells to switch from producing IgE to producing IgG4, which serves as a protective barrier against future allergen exposure.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Epicutaneous) |
| Protein Binding | Variable (Interacts with IgE/IgG) |
| Half-life | Hours (Proteins); Years (Immune Memory) |
| Tmax | 15-30 minutes (Local); 2-8 hours (Systemic) |
| Metabolism | Proteolytic degradation |
| Excretion | Renal (Metabolites) |
Castanea Sativa Leaf is classified as a Non-Standardized Plant Allergenic Extract. It belongs to the broader category of Biological Response Modifiers. Related medications include extracts for Oak, Beech, and various grass pollens used in similar diagnostic and therapeutic protocols.
Common questions about Castanea Sativa Leaf
Castanea Sativa Leaf extract is primarily used by allergy specialists to diagnose and treat allergies related to the sweet chestnut tree. In diagnostic settings, it is used in skin prick tests to confirm if a patient is allergic to chestnut proteins. Therapeutically, it is used in allergen immunotherapy, commonly known as allergy shots, to help the body build tolerance over time. This treatment is particularly helpful for patients with allergic rhinitis or asthma that is triggered by chestnut pollen. It is not a treatment for acute allergic reactions but rather a long-term strategy to reduce overall sensitivity.
The most common side effects are localized to the site of the injection or skin test. Patients frequently experience redness, itching, and a raised bump (wheal) at the site where the extract was applied. These reactions are usually mild and resolve within a few hours to a day. Some patients may also experience a 'late-phase' reaction where swelling increases several hours after the injection. While these local effects are common, they are generally not dangerous. However, any reaction that spreads beyond the injection site should be reported to a doctor immediately.
It is strongly advised to avoid alcohol consumption on the days you receive a Castanea Sativa Leaf injection. Alcohol causes the blood vessels to dilate, which can potentially speed up the absorption of the allergen into your bloodstream. This increased absorption rate can elevate the risk of a systemic allergic reaction or make a reaction more severe. Furthermore, alcohol can mask the early symptoms of an allergic reaction, making it harder for you or your doctor to identify a problem. For your safety, wait at least 24 hours after your injection before consuming alcohol.
The safety of starting Castanea Sativa Leaf immunotherapy during pregnancy has not been established, and it is generally avoided. The main risk is not the extract itself, but the potential for a severe allergic reaction (anaphylaxis) in the mother, which could deprive the fetus of oxygen. However, if a woman is already on a stable maintenance dose of immunotherapy and becomes pregnant, her allergist may decide to continue the treatment. This decision is made on a case-by-case basis, weighing the risks of stopping therapy against the risks of a reaction. Always inform your doctor immediately if you become pregnant during treatment.
Castanea Sativa Leaf immunotherapy is a long-term commitment and does not provide immediate relief. Most patients begin to notice a reduction in their allergy symptoms during the first year of treatment, usually after they have reached the maintenance dose. Significant improvement typically occurs by the second year of therapy. To achieve long-lasting results that continue even after the injections stop, a full course of 3 to 5 years is generally recommended. If no improvement is seen after one year of maintenance therapy, your doctor may re-evaluate the treatment plan.
Yes, you can stop taking Castanea Sativa Leaf injections suddenly without experiencing physical withdrawal symptoms. Unlike many other medications, allergenic extracts do not create a chemical dependency in the body. However, stopping the treatment before the recommended 3-to-5-year period significantly increases the chance that your allergy symptoms will return. If you miss several doses, you cannot simply restart at the same level; your doctor will need to reduce the dose and gradually build it back up to ensure your safety. Always discuss your plans with your allergist before discontinuing treatment.
If you miss a scheduled immunotherapy injection, you should contact your allergist as soon as possible to reschedule. Do not attempt to 'double up' on doses. The protocol for a missed dose depends on how long it has been since your last injection. If only a few days have passed, you may be able to continue with your scheduled dose. However, if several weeks have passed, your immune system's tolerance may have slightly decreased, and your doctor will likely need to give you a lower dose to prevent a reaction. Consistency is key to the success of this therapy.
There is no clinical evidence to suggest that Castanea Sativa Leaf extract causes weight gain. The extract consists of proteins and polysaccharides administered in very small quantities, which do not have metabolic or caloric effects on the body. Unlike systemic corticosteroids, which are sometimes used to treat allergies and can cause weight gain, allergenic extracts work specifically on the immune system's response to a particular plant. If you experience unexplained weight gain while on this therapy, it is likely due to other factors and should be discussed with your primary care physician.
Castanea Sativa Leaf can be taken with many other medications, but some interactions are very serious. You must inform your doctor if you are taking beta-blockers, ACE inhibitors, or MAO inhibitors, as these can make allergic reactions more dangerous or harder to treat. Antihistamines and cold medicines can interfere with the results of diagnostic skin tests and should be stopped several days before testing. Most other routine medications for conditions like diabetes or high cholesterol do not interact with allergenic extracts. Always provide a full list of your medications to your allergist.
The concept of 'generic' vs. 'brand name' is slightly different for allergenic extracts like Castanea Sativa Leaf. These are biological products, and while multiple laboratories may produce an extract of the Sweet Chestnut leaf, they are not considered identical or interchangeable. Each manufacturer's extract may have different concentrations of specific proteins. Therefore, if your doctor switches you from one manufacturer's extract to another, they will usually treat it as a new medication and restart the dosing at a lower level to ensure your safety. These products are generally referred to by their common name rather than a brand name.